Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 6, 2008, Pages 642.e1-642.e6

  Fagotti, Anna ^a   Ferrandina, Gabriella ^b   Fanfani, Francesco ^b   Garganese, Giorgia ^b   Vizzielli, Giuseppe ^a   Carone, Vito ^b   Salerno, Maria Giovanna ^a   Scambia, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

cytoreduction; laparoscopy; ovarian cancer

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CARCINOMATOSIS; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; LAPAROSCOPY; LIVER METASTASIS; MAJOR CLINICAL STUDY; OMENTUM; OVARY CARCINOMA; PREDICTION AND FORECASTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPLEEN;

EID: 57149125155     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.06.052     Document Type: Article

References (26)

1. Eisenkop S.M., Friedman R.L., and Wang H.J. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer. Gynecol Oncol 69 (1998) 103-108
2. Bristow R.E., Tomacruz S.R., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20 (2002) 1248-1259
3. Brockbank E., Ind T., Barton D., et al. Preoperative predictors of suboptimal primari surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer. Int J Gynecologic Cancer 14 (2004) 42-50
4. Chi D.S., Venkatraman E.S., Masson V., and Hoskins W.J. The ability of preoperative serum CA 125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecol Oncol 77 (2000) 227-231
5. Saygili U., Guclu S., Uslu T., Erten O., Demir N., and Onvural A. Can serum CA 125 levels predict the optimal primary cytoreduction in patients with advanced ovarian carcinoma?. Gynecol Oncol 86 (2002) 57-61
6. Memarzadeh S., Lee S.B., Berek J.S., and Farias-Eisner R. CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer. Int J Gynecol Cancer 13 (2003) 120-124
7. Bristow R.E., Duska L.R., Lambrou N.C., et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89 (2000) 1532-1540
8. Dowdy S.C., Mullany S.A., Brandt K.R., Huppert B.J., and Cliby W.A. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer 101 (2004) 346-352
9. Qayyum A., Coakley F.V., Westphalen A.C., Hricak H., Okuno W.T., and Powell B. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 96 (2005) 301-306
10. Axtell A.E., Lee M.H., Bristow R.E., et al. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol 25 (2007) 384-389
11. Everett E.N., Heuser C.C., Pastore L.M., et al. Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer. Am J Obstet Gynecol 193 (2005) 568-574
12. Berchuck A., Iversen E.S., Lancaster J.M., et al. Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. Am J Obstet Gynecol 190 (2004) 910-925
13. Leblanc E., Querleu D., Narducci F., Occelli B., Papageorgiou T., and Sonoda Y. Laparoscopic restaging of early stage invasive adnexal tumors: a 10-year experience. Gynecol Oncol 94 (2004) 624-629
14. Manolitsas T.P., and Fowler J.M. Role of laparoscopy in the management of the adnexal mass and staging of gynecologic cancers. Clin Obstet Gynecol 44 (2001) 495-521
15. Littell R.D., Hallonquist H., Matulonis U., Seiden M.V., Berkowitz R.S., and Duska L.R. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma. Gynecol Oncol 103 (2006) 570-574
16. Fagotti A., Fanfani F., Ludovisi M., et al. Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study. Gynecol Oncol 96 (2005) 729-735
17. Deffieux X., Castaigne D., and Pomel C. Role of laparoscopy to evaluate candidates for complete cytoreduction in advanced stages of epithelial ovarian cancer. Int J Gynecol Cancer 16 Suppl (2006) 35-40
18. Angioli R., Palaia I., Zullo M.A., et al. Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecol Oncol 100 (2006) 455-461
19. Fagotti A., Ferrandina M.G., Fanfani F., et al. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol 13 (2006) 1156-1161
20. Simon R. Optimal two stage design for phase II clinical trials. Control Clin Trials 10 (1989) 1-10
21. Chassagne D., Sismondi P., Horiot J.C., et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 26 (1993) 195-202
22. Sharma S., Driscoll D., Odunsi K., Venkatadri A., and Lele S. Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients. Am J Obstet Gynecol 193 (2005) 2077-2082
23. Aletti G.D., Dowdy S.C., Podratz K.C., and Cliby W.A. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol 197 (2007) 676.e1-676.e7
24. Aletti G.D., Santillan A., Eisenhauer E.L., et al. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model. Gynecol Oncol 107 (2007) 99-106
25. Bristow R.E., Montz F.J., Lagasse L.D., Leuchter R.S., and Karlan B.Y. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol 72 (1999) 278-287
26. Winter III W.E., Maxwell G.L., Tian C., et al., Gynecologic Oncology Group. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 26 (2008) 83-89